CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to SCLP.L

SCIB1 or iSCIB1+ DNA vaccine

Phase 2
Scancell Holdings plc (SCLP.L)

Phase 2

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Jan '27
SCLP.LPhase 2

SCIB1 or iSCIB1+ DNA vaccine Phase 2 Est. Readout

SCIB1 or iSCIB1+ DNA vaccine
Jan 2027~
CT.gov
00%
Competitive Landscape

0 competitors in Malignant Melanoma

View Full Landscape
Drug Information

Target Indication

Malignant Melanoma

Clinical Trial

NCT04079166

Last updated: 6/28/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.